Cargando…

Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets

Detalles Bibliográficos
Autores principales: Yamout, Bassem I, Rieckmann, Peter, Centonze, Diego, Giovannoni, Gavin, Hua, Le H., Oreja-Guevara, Celia, Selchen, Daniel, Sørensen, Per Soelberg, Vermersch, Patrick, Wiendl, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117599/
http://dx.doi.org/10.1016/j.msard.2022.103621
_version_ 1784710343198507008
author Yamout, Bassem I
Rieckmann, Peter
Centonze, Diego
Giovannoni, Gavin
Hua, Le H.
Oreja-Guevara, Celia
Selchen, Daniel
Sørensen, Per Soelberg
Vermersch, Patrick
Wiendl, Heinz
author_facet Yamout, Bassem I
Rieckmann, Peter
Centonze, Diego
Giovannoni, Gavin
Hua, Le H.
Oreja-Guevara, Celia
Selchen, Daniel
Sørensen, Per Soelberg
Vermersch, Patrick
Wiendl, Heinz
author_sort Yamout, Bassem I
collection PubMed
description
format Online
Article
Text
id pubmed-9117599
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-91175992022-05-19 Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets Yamout, Bassem I Rieckmann, Peter Centonze, Diego Giovannoni, Gavin Hua, Le H. Oreja-Guevara, Celia Selchen, Daniel Sørensen, Per Soelberg Vermersch, Patrick Wiendl, Heinz Mult Scler Relat Disord Article Published by Elsevier B.V. 2022-03 2022-05-19 /pmc/articles/PMC9117599/ http://dx.doi.org/10.1016/j.msard.2022.103621 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Yamout, Bassem I
Rieckmann, Peter
Centonze, Diego
Giovannoni, Gavin
Hua, Le H.
Oreja-Guevara, Celia
Selchen, Daniel
Sørensen, Per Soelberg
Vermersch, Patrick
Wiendl, Heinz
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
title Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
title_full Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
title_fullStr Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
title_full_unstemmed Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
title_short Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
title_sort expert opinion on covid-19 vaccination and the use of cladribine tablets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117599/
http://dx.doi.org/10.1016/j.msard.2022.103621
work_keys_str_mv AT yamoutbassemi expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT rieckmannpeter expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT centonzediego expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT giovannonigavin expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT hualeh expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT orejaguevaracelia expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT selchendaniel expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT sørensenpersoelberg expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT vermerschpatrick expertopiniononcovid19vaccinationandtheuseofcladribinetablets
AT wiendlheinz expertopiniononcovid19vaccinationandtheuseofcladribinetablets